Related Experiment Videos
University-affiliated venture capital funds
Health Affairs (Project Hope)
|January 1, 1994
Summary
University-affiliated venture capital funds directly support faculty innovations. Early evidence suggests these models are promising for commercializing biomedical technologies and offer guidelines for future initiatives.
Area of Science:
- Biomedical Technology Commercialization
- University Technology Transfer
- Venture Capital in Academia
Background:
- Academic institutions increasingly engage in commercializing faculty research.
- University-industry collaborations and licensing are common.
- Direct participation through venture capital funds is an emerging model.
Purpose of the Study:
- To review university/industry collaborations.
- To focus on university-affiliated venture capital funds.
- To provide an early perspective on these funds for biomedical technology commercialization.
Main Methods:
- Review of existing literature on university/industry collaborations.
- Focus on three case studies of university-affiliated venture capital funds.
- Analysis of early performance and mechanisms of these funds.
Main Results:
- University venture capital funds represent direct academic participation in new ventures.
- These funds aim to bring new biomedical technologies into practical use.
- Early data suggests these models are effective mechanisms for innovation.
Conclusions:
- University-affiliated venture capital funds are a direct pathway for commercializing academic inventions.
- While new, these models show promise for biomedical technology diffusion.
- Early findings can inform the development of more efficient future initiatives.